In immune-hot cases, characterized by substantial CD8+ T cell infiltration and typically associated with better response to immunotherapy34,35, we observed both tumour (attacker) cells and infiltrating CD8+ (defender) T cells within the tumour region, suggesting an active immune response. Here, CD8A is linked to neoplasm.